SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000059478-24-000065
Filing Date
2024-02-21
Accepted
2024-02-21 11:44:37
Documents
132
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lly-20231231.htm   iXBRL 10-K 3213503
2 EX-4.3 lly-20231231x10kexhibit43.htm EX-4.3 23733
3 EX-10.3 lly-20231231x10kexhibit103.htm EX-10.3 108505
4 EX-10.4 lly-20231231x10kexhibit104.htm EX-10.4 114764
5 EX-10.5 lly-20231231x10kexhibit105.htm EX-10.5 107031
6 EX-10.10 lly-20231231x10kexhibit1010.htm EX-10.10 86262
7 EX-21 lly-20231231x10kexhibit21.htm EX-21 73456
8 EX-23 lly-20231231x10kexhibit23.htm EX-23 2227
9 EX-31.1 lly-20231231x10kexhibit311.htm EX-31.1 10266
10 EX-31.2 lly-20231231x10kexhibit312.htm EX-31.2 10204
11 EX-32 lly-20231231x10kexhibit32.htm EX-32 7107
12 EX-97 lly-20231231x10kexhibit97.htm EX-97 42355
18 lly-20231231_g1.jpg GRAPHIC 88484
  Complete submission text file 0000059478-24-000065.txt   18280701

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20231231.xsd EX-101.SCH 93603
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20231231_cal.xml EX-101.CAL 142783
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20231231_def.xml EX-101.DEF 474261
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20231231_lab.xml EX-101.LAB 1264350
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20231231_pre.xml EX-101.PRE 807034
134 EXTRACTED XBRL INSTANCE DOCUMENT lly-20231231_htm.xml XML 3747315
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06351 | Film No.: 24657434
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)